Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Troy Hendrickson"'
Autor:
Troy Hendrickson, Cristina Lupo, Guillermo Bauza, Liliana Tavares, Shannon Ingram, Sufen Wang, Michael Moreno, Ennio Tasciotti, Miguel Valderrabano, Francesca Taraballi
Publikováno v:
Materials Today Bio, Vol 14, Iss , Pp 100240- (2022)
Atrial fibrillation induced stroke accounts for up to 15% of all strokes. These strokes are caused approximately 90% of the time by clot formation in the left atrial appendage (LAA). To prevent these clots, the most common approach is to administer b
Externí odkaz:
https://doaj.org/article/971c26a01fda406995c101f902928fc8
Publikováno v:
Circulation Research. 131
Atrial fibrillation (AF) is the most common cardiac arrhythmia with a 1 in 4 lifetime risk. AF impairs cardiac function and increases the risk of stroke and heart attack. Although this is a common and harmful disease, little is known about the molecu
Publikováno v:
Circulation Research. 131
Mutations in polycystin-1 (PC1) cause 85% of autosomal dominant polycystic kidney disease cases. This disease is characterized by progressive renal disease and multiple cardiovascular alterations. Evidence suggests that cardiovascular disease precede
Autor:
Troy Hendrickson, Cristina Lupo, Guillermo Bauza, Liliana Tavares, Shannon Ingram, Sufen Wang, Michael Moreno, Ennio Tasciotti, Miguel Valderrabano, Francesca Taraballi
Publikováno v:
Materials today. Bio. 14
Atrial fibrillation induced stroke accounts for up to 15% of all strokes. These strokes are caused approximately 90% of the time by clot formation in the left atrial appendage (LAA). To prevent these clots, the most common approach is to administer b
Abstract P464: Cardiac Dysfunction In A Mouse Model For Autosomal Dominant Polycystic Kidney Disease
Autor:
William Perez, Gabriele G. Schiattarella, Francisco Altamirano, Troy Hendrickson, Joseph A. Hill
Publikováno v:
Circulation Research. 129
Mutations in polycystin-1 (PC1) cause autosomal dominant polycystic kidney disease (ADPKD), a disorder that manifests with cardiac hypertrophy and dysfunction. We recently showed that cardiomyocyte-specific PC1 KO mice exhibit both systolic and diast
Publikováno v:
Circulation Research. 129
Patients with Autosomal Dominant Polycystic Kidney disease (ADPKD) have multiple cardiovascular manifestations, including increased susceptibility to arrhythmias. Mutations in polycystin-1 (PC1) encoding gene accounts for 85% cases of ADPKD, whereas
Autor:
Jafet Ortiz-Quintero, Camila López-Crisosto, Magda C. Díaz-Vesga, Sebastian Leiva-Navarrete, William Perez, Francisco Altamirano, Mario Chiong, Andrea Ramírez-Sagredo, Sergio Lavandero, Troy Hendrickson, Valeria Garrido-Moreno, Clara Quiroga, Zully Pedrozo, Ignacio Norambuena-Soto, Valentina Parra
Publikováno v:
FASEB journal : official publication of the Federation of American Societies for Experimental BiologyREFERENCES. 35(8)
Polycystin-1 (PC1) is a transmembrane protein found in different cell types, including cardiomyocytes. Alterations in PC1 expression have been linked to mitochondrial damage in renal tubule cells and in patients with autosomal dominant polycystic kid
Autor:
Chiara, Mancino, Troy, Hendrickson, Lauren V, Whitney, Francesca, Paradiso, Sara, Abasi, Ennio, Tasciotti, Francesca, Taraballi, Anthony, Guiseppi-Elie
Publikováno v:
Nanomedicine: Nanotechnology, Biology and Medicine. 44:102567
Myocardial infarction remains the leading cause of death in the western world. Since the heart has limited regenerative capabilities, several cardiac tissue engineering (CTE) strategies have been proposed to repair the damaged myocardium. A novel ele
Autor:
Lauren V. Whitney, Francesca Taraballi, Chiara Mancino, Maham Rahimi, Troy Hendrickson, Christopher Tsao
Publikováno v:
Nanomedicine : nanotechnology, biology, and medicine. 33
Cardiovascular diseases are the number one killer in the world. 1 , 2 Currently, there are no clinical treatments to regenerate damaged cardiac tissue, leaving patients to develop further life-threatening cardiac complications. Cardiac tissue has mul
Autor:
Aaron Shi, Laura Pandolfi, Silvia Minardi, Ennio Tasciotti, Francesca Taraballi, Xin Wang, Gianluca Storci, Troy Hendrickson, Cristina Lupo, Christopher Tsao, Michael Evangelopoulos
Publikováno v:
ACS applied materialsinterfaces. 10(51)
The use of nanomaterials as carriers for the delivery of growth factors has been applied to a multitude of applications in tissue engineering. However, issues of toxicity, stability, and systemic effects of these platforms have yet to be fully unders